You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》艾美疫苗(06660.HK)公開發售超購2.15倍 一手中籤率60%
阿思達克 10-05 08:38
內地第二大疫苗商艾美疫苗(06660.HK)公布招股結果,每股發售價定為16.16元。香港公開發售部分錄得超額認購約2.15倍。每手200股計,一手中籤率60.02%,認購5手(1,000股)穩獲一手。該股將於明日(6日)掛牌。聯席保薦人為高盛、中金、中信建投及麥格理。 公司上市料淨集資約7,001萬元,其中約4,200萬元將用於推進在研疫苗的研發及持續豐富疫苗管線;約2,450萬元將用於為建設新生產設施的資本開支提供資金,以擴大新疫苗產品的產能;及約351萬元將投入銷售及營銷活動,包括擴大銷售及營銷團隊,為更多學術推廣活動撥付資金及為新疫苗產品開展上市前營銷活動。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account